Dr. Agarwals Health Care Ltd held a crucial meeting of equity shareholders to approve its amalgamation scheme with Dr. Agarwal's Eye Hospital Limited, following an NCLT order. The outcome awaits consolidated voting results.
Dr. Agarwals Health Care Ltd Amalgamation Meeting
Dr. Agarwals Health Care Ltd convened a significant meeting of its equity shareholders on May 05, 2026, following an order from the National Company Law Tribunal (NCLT).
The primary agenda was to discuss and approve the Scheme of Amalgamation, which involves merging Dr. Agarwal's Eye Hospital Limited (the transferor company) with Dr. Agarwal's Health Care Limited (the transferee company). This corporate restructuring is being executed under the provisions of Sections 230 to 232 of the Companies Act, 2013.
What Just Happened
A total of 47 shareholders, comprising 17 from the Promoters and Promoter Group and 30 from the Public category, were present at the meeting. The total number of shareholders recorded on June 03, 2026, was 43,122.
Why This Matters
This shareholder meeting represents a critical step in the proposed amalgamation process. The company is fulfilling a key procedural requirement mandated by the NCLT. The approval from shareholders is essential for the scheme to proceed further.
Meeting Proceedings
The meeting was presided over by Shri L N Gupta, who confirmed the presence of the necessary quorum. Several procedural steps were undertaken, including the availability of the Register of Members, Proxy Register, NCLT Order, and the Scheme documents for inspection. Voting was conducted through multiple channels: remote e-voting, venue e-voting, and physical polling papers. A Scrutinizer, Shri Shivam Parashar, has been appointed to oversee the voting and consolidate the results from all channels.
What to Track Next
Investors should closely monitor the upcoming announcement of the consolidated voting results. This outcome will determine the shareholders' approval for the amalgamation scheme and dictate the next steps in the restructuring process for the Dr. Agarwal group entities.